|

Liothyronine (L-T3) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: L-T3

Pipeline

Phase 1/2: 1

Top Sponsors

  • Sabine Mueller, MD, PhD1

Indications

  • Medulloblastoma Recurrent1
  • Medulloblastoma, Childhood1
  • Medulloblastoma1
  • Cancer1

San Francisco, California1 trial

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

University of California, San Francisco

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.